We do not support your browser. Please take a moment and upgrade to the most recent version of Internet Explorer.

NCATS Funding - Repurposing Existing Therapeutics to Address COVID-19
Deadline: June 05, 2020 02:00 PM

Save this event to your calendar.  Download to Outlook Download to iCal

National Center for Advancing Translational Sciences (NCATS) is issuing this Notice of Special Interest (NOSI) to highlight the urgent need for research on the 2019 novel coronavirus (SARS-CoV-2) and the disease it causes, i.e., “coronavirus disease 2019” (COVID-19). NCATS is particularly interested in projects that repurpose existing drugs or biologics (existing therapeutics) that have already begun or completed a Phase I clinical trial.

The hypothesis for proposed studies must be developed using innovative processes to identify the therapeutic/indication pair. Examples include the following:
  • Testing a publicly posted therapeutic candidate for use to treat COVID-19. Examples include clinical candidate therapeutics in documents publicly posted by the World Health Organization (types/classes of candidate therapeutics) and (candidates for clinical evaluation).
  • Testing a candidate therapy to treat COVID-19 that was already identified with a publicly available computational approach.
  • Testing of existing therapeutic candidates that work on mechanistic targets shared among other viruses that may be relevant to SARS-CoV-2.

NCATS is soliciting applications to PAR-17-465, PAR-18-462, and PAR-18-332. Read full details at NOT-TR-20-012.

Release Date: March 27, 2020
First Available Due Date: June 05, 2020
Expiration Date: October 17, 2020

Return to Deadline Listings